Inj eflapegrastim-xnst 0.1mg
Products billed under this code include Rolvedon.
Payment limit per 0.1 MG, by effective quarter, 3Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J1449
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Rolvedon | Spectrum Pharmaceuticals, Inc. | 76961-0101-01 | 132 | $4,939.572 |
| Rolvedon | Assertio Specialty Pharmaceuticals, LLC | 82497-0132-01 | 132 | $4,939.572 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $37.421 | −$1.141 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted September 17, 2026 |
| 3Q26 | $38.562 | −$0.393 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted September 15, 2026 |
| 2Q26 | $38.955 | +$15.405 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted September 15, 2026 |
| 1Q26 | $23.55 | +$2.676 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted September 15, 2026 |
| 4Q25 | $20.874 | −$0.243 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted September 8, 2026 |
| 3Q25 | $21.117 | −$1.491 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted March 10, 2026 |
| 2Q25 | $22.608 | +$0.473 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted March 10, 2026 |
| 1Q25 | $22.135 | −$0.619 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted December 19, 2025 |
| 4Q24 | $22.754 | −$3.42 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted June 11, 2025 |
| 3Q24 | $26.174 | −$1.561 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted June 11, 2025 |
| 2Q24 | $27.735 | −$1.944 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted March 11, 2025 |
| 1Q24 | $29.679 | −$1.665 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted December 19, 2024 |
| 4Q23 | $31.344 | −$0.427 | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted October 10, 2024 |
| 3Q23 | $31.771 | – | 0.1 MG | Inj eflapegrastim-xnst 0.1mg | v1, posted June 5, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024